$DOCUBullishLow

Dear Docusign Stock Fans, Mark Your Calendars for June 4

DocuSign shares have fallen 36.58% over 52 weeks and 17.84% YTD, but rose 24.69% over three months and 17.18% in the past month, ahead of earnings. After Q4 FY2026 results on March 17, revenue rose 7.8% YoY to $836.9M (above $828.2M est.); non-GAAP EPS was $1.01 (vs $0.95). Billings exceeded $1B for the first time. Q1 FY2027 revenue guidance: $822M–$826M. Analysts rate DOCU “Hold” with $58.81 average target.

9/10
3/10
Low
Bullish
Ahead of the June 4 earnings calendar mention (article frames upcoming timing, but no new guidance beyond what’s already cited).
Improving fundamentals narrative aligns with the described post-earnings price strength.

Earnings beat plus billings milestone and new IAM traction support a valuation re-rating, but EPS guidance softness keeps near-term uncertainty.

DocuSign reported Q4 FY2026 results with revenue/EPS beats, billings crossing $1B, and issued Q1 FY2027 and FY2027 guidance.

Bias toward upside/mean reversion versus depressed valuation, with volatility around Q1 EPS expectations.

Background

The piece summarizes DocuSign’s recent performance, valuation positioning versus history/industry, and the key takeaways from its Q4 FY2026 earnings and subsequent guidance.

Why it matters

The market is portrayed as shifting from uncertainty toward improving fundamentals, supported by billings growth and IAM ARR contribution, while near-term EPS expectations remain a potential drag.

Market relevance

DOCU is positioned as a discounted SaaS name after an earnings beat and billings milestone, with upside tied to execution on platform evolution.

Market effects

Reinforces demand durability for e-signature/CLM platforms and highlights IAM as a monetization lever for SaaS peers.

No specific regional effects cited.

No explicit global macro/regional drivers cited.

Alternative perspectives

Despite valuation discount, the Street expects Q1 EPS to decline ~5% YoY, which can limit multiple expansion if margins don’t hold.

Subscription/pro services mix and competitive pressure are flagged as ongoing risks, which may keep forward estimates sensitive to execution.

Key entities

  • DocuSign

    Subject of the article; reported Q4 FY2026 results and provided Q1 FY2027 and FY2027 revenue guidance.

  • IAM

    DocuSign’s newer growth initiative cited for generating $350M+ annual recurring revenue and increasing its ARR mix.

Related articles

$LULUMed

Stock Market Today: Dow Futures Gain, S&P 500 Slips As Trump Floats Meeting Iran's Supreme Leader— Lulule

U.S. stock futures were mixed Friday: Nasdaq 100 and S&P 500 slipped while Dow futures rose after a mixed prior close. President Trump said he would consider meeting Iran’s Supreme Leader Ayatollah Mojtaba Khamenei if diplomacy progresses. Treasury yields were 4.46% (10-year) and 4.03% (2-year); FedWatch priced a 96.4% chance of no June rate change. Lululemon, Docusign (-4.73%), Samsara (-5.14%), and Keel (-8.94% on $350m convertibles) were among movers.

$LULUHighAI 9/10

Stocks making the biggest moves after hours: Lululemon Athletica, ServiceTitan, Argan and more

After-hours movers: Lululemon shares fell 10% after it cut full-year earnings and revenue guidance and its current-quarter outlook missed analyst expectations, per LSEG. Docusign slipped 4% as its Q2 revenue outlook ($865M–$869M) met but didn’t beat estimates. Guidewire dropped 16% on weaker adjusted gross margin. ServiceTitan rose 12% after raising full-year guidance.

$DOCUMedAI 9/10

DocuSign Delivers Beat-And-Raise Q1, But Investors Aren't Impressed - Docusign (NASDAQ:DOCU)

DocuSign reported Q1 revenue of $830.2 million, slightly above the $824.77 million consensus, and adjusted EPS of $1.09 versus $0.99 expected, according to Benzinga Pro. Revenue rose 9% YoY; free cash flow was $289.4 million. The company repurchased $317.5 million of stock and raised FY revenue guidance to $3.49–$3.502 billion. Shares were down 4.02% after hours to $48.85.

$DOCUMedAI 9/10

DocuSign (DOCU) Q1 Earnings Report Preview: What To Look For

DocuSign will report Q1 results Thursday after the bell, according to the article. The company’s prior quarter revenue was $836.9 million (+7.8% YoY), but it missed annual recurring revenue estimates. For Q1, analysts expect revenue +8.1% YoY. The article cites an average analyst price target of $59.88 vs. $55.18.